Jefferies Opens BCR With Buy

by Monica Gerson, Benzinga Staff Writer
April 1, 2011 5:48 AM | 13 seconds read |
Analysts at Jefferies initiate coverage of C.R. Bard Inc BCR with a “buy” rating. The target price for BCR is set to $115. BCR shares gained 0.83% to close at $99.36 yesterday. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: InitiationAnalyst RatingsHealth CareHealth Care EquipmentJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!